SEC Form 4 · accession 0001127602-17-015752
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald G Gelbman
Director
Period of report
Mar 24, 2017
Accepted (ET)
Apr 27, 2017 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 24, 2017 | M | 8,580 | $27.24 | A | 58,268 | D | |
| Common StockF1 | Mar 24, 2017 | S | 8,580 | $40.00 | D | 49,688 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F2 | $27.24 | Mar 24, 2017 | M | 8,580 | D | Jul 29, 2011 | Jul 29, 2017 | Common Stock | 8,580 | 0 | D |
Explanation of responses
- F1Cashless exercise and sale of net shares pursuant to a 10b5-1 trading plan.
- F2Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.